BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAMED - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAMED
X-ORIGINAL-URL:https://samed.org.za
X-WR-CALDESC:Events for SAMED
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20260707T100000
DTEND;TZID=Africa/Johannesburg:20260707T110000
DTSTAMP:20260625T234725
CREATED:20260611T120856Z
LAST-MODIFIED:20260611T120856Z
UID:16853-1783418400-1783422000@samed.org.za
SUMMARY:Code Forum: Legal Masterclass
DESCRIPTION:Could your pricing strategy\, rebate structure\, or customer incentives expose your business to competition law risk? \nAs competition authorities continue to scrutinise pricing practices across industries\, MedTech companies must ensure that their commercial strategies remain compliant while supporting growth\, innovation\, and market access. \nCompetition law remains one of the most important compliance considerations for MedTech companies operating in South Africa. Issues relating to excessive pricing\, incentives\, rebates\, and price discrimination can carry significant regulatory\, financial\, and reputational consequences if not properly understood and managed. \nThis practical masterclass presented by Bowmans will unpack the key principles governing these areas\, including recent developments and the application of the current Section 18 Exemption Framework. \nPresenters:\nHeather Irvine\, Partner\, Bowmans\nJulie Oppenheim\, Head: Pharmaceuticals and Healthcare Sector\, Bowmans \nThe session will explore: \n\nExcessive pricing and how it is assessed under competition law\nThe legal considerations surrounding incentives and rebate structures\nPrice discrimination and potential compliance risks\nThe purpose and practical implications of the current Section 18 exemption framework\nKey considerations for MedTech companies when developing commercial\, pricing\, and market access strategies\nPractical guidance to help organisations identify and mitigate competition law risks\n\nWhy Attend? \nWhether you are developing pricing strategies\, negotiating contracts\, engaging customers\, or supporting market access activities\, understanding competition law is essential to protecting your business and maintaining compliance. \nThis session will provide practical insights to help members: \n\nStrengthen compliance and governance practices\nBetter understand regulatory expectations\nAssess commercial arrangements and pricing models\nReduce legal and reputational risk\nNavigate the evolving healthcare regulatory environment with confidence\n\nWho Should Attend? \n\nExecutive Managers\nMarketing and Sales Managers\nRegulatory and Compliance Professionals\nMarket Access Specialists\nFinance Managers\n\nJoin us for this important legal masterclass and gain practical guidance from leading competition law experts on navigating complex commercial and regulatory considerations within the MedTech sector. \nRegister: Click Here
URL:https://samed.org.za/event/code-forum-legal-masterclass/
LOCATION:Virtual
CATEGORIES:Code,Compliance
ATTACH;FMTTYPE=image/png:https://samed.org.za/wp-content/uploads/2026/06/Graphic-lower-resolution-Teams-scaled.png
ORGANIZER;CN="SAMED":MAILTO:communication@samed.org.za
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20260722T080000
DTEND;TZID=Africa/Johannesburg:20260722T101500
DTSTAMP:20260625T234725
CREATED:20260610T124555Z
LAST-MODIFIED:20260610T124616Z
UID:16846-1784707200-1784715300@samed.org.za
SUMMARY:CEO Pulse
DESCRIPTION:The healthcare and MedTech landscape is undergoing significant transformation. Join this forum for a strategic briefing from leading voices across business\, healthcare funding\, and healthcare policy as they unpack the developments shaping South Africa’s healthcare future. \nGain exclusive insights into economic priorities\, healthcare financing\, regulatory developments\, and the broader policy environment that will influence business strategy\, investment decisions\, market access\, and healthcare delivery in the years ahead. \nProgramme \n08:00 \nBUSA and B4SA Update  \npresented by Khulekani Mathe\, CEO\, Business Unity South Africa (BUSA) \n  \n08:30 \nBuilding a Sustainable Health Funding Ecosystem: Priorities\, Partnerships\, and the Future of Healthcare Financing \npresented by Thoneshan Naidoo\, CEO\, Health Funders Association (HFA) \n  \n09:15 \nSouth African Healthcare in Transition: Key Regulatory and Policy Developments \npresented by Elsabé Klinck\, Managing Director\, Klinck & Samuels \n  \nWhy This Matters for MedTech Leaders \nThe decisions being made today across government\, healthcare funding\, regulation\, and business will directly impact the future operating environment for MedTech companies. \nThis forum will provide practical insight into: \n\nThe economic and policy landscape shaping healthcare and business in South Africa\nDevelopments in NHI\, healthcare funding\, and reimbursement environments\nRegulatory and legislative changes affecting MedTech companies\nEmerging risks\, opportunities\, and strategic considerations for industry leaders\nThe role of business and industry in shaping a sustainable healthcare ecosystem\n\nWhether your focus is growth\, market access\, regulatory compliance\, investment planning\, or healthcare innovation\, this session will equip you with the intelligence needed to make informed strategic decisions. \n Who Should Attend? \n\nChief Executive Officers (CEOs)\nManaging Directors\nGeneral Managers\nExecutive Managers\nSenior Leaders\nBusiness Unit Heads\nMarket Access\, Regulatory\, Public Affairs\, and Strategy Executives\n\nRegister: Click Here
URL:https://samed.org.za/event/ceo-pulse-2/
LOCATION:Virtual
CATEGORIES:Captains of Industry
ATTACH;FMTTYPE=image/png:https://samed.org.za/wp-content/uploads/2026/06/CEO-Pulse-Invitation-scaled.png
ORGANIZER;CN="SAMED":MAILTO:communication@samed.org.za
END:VEVENT
END:VCALENDAR